Ocugen expects $53.5M from stock sale amid efforts to bring Covaxin to the U.S.
February 24, 2022 at 13:09 PM EST
Ocugen is continuing its efforts to bring a Covid-19 vaccine developed in India to the United States.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|